Univercells and Exothera announce Thibault Jonckheere as new CEO of Exothera

June 1st 2021


Univercells S.A. (“Univercells”) and Exothera S.A. (the “Company”) are pleased to announce that effective June 1, 2021, Thibault Jonckheere has been appointed as Chief Executive Officer of Exothera, a Univercells company and uniquely positioned full-service viral vector Contract Development and Manufacturing Organization (CDMO). The appointment of Thibault is the next step in driving Exothera to realize its vision of making cell and gene therapies (C&GT) available to all. Please discover the press release here.